News Cartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis – Cartesian ⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January 31, 2023 –…Super UserFebruary 6, 2023
News AURP BIO Health Caucus 2023 AURP’s BioHealth Caucus will examine topics, including: Economic impact of the biotech industry in the…Super UserFebruary 6, 2023
News Montgomery County Perfect Home for ARPA-H The newly established Advanced Research Projects Agency for Health (ARPA-H) will accelerate cutting-edge biomedical and…Super UserFebruary 6, 2023
News TEDCO chooses 24 MD companies for SBIR/STTR Proposal Lab cohort TEDCO, Maryland’s economic engine for technology companies, Tuesday announced the selection of 24 Maryland companies to participate…Super UserFebruary 6, 2023
News WJLA: Maryland’s Medcura Recognized For Innovative Biosurgical Tech (Video) Prince George's County, Maryland based Medcura’s is pioneering a proprietary biosurgical technology that has repeatedly…Super UserFebruary 3, 2023
News Quality Biological Inks 24,000 SF Lease at Shady Grove Development Park in Gaithersburg, MD GAITHERSBURG, M.D. – Transwestern Real Estate Services (TRS) announces Quality Biological, Inc. has signed a 24,000-square-foot lease at…Super UserFebruary 2, 2023
News Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore for Study Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore, to Study TNX-1500 (Fc-modified anti-CD40L…Super UserFebruary 2, 2023
News AMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia CHARLOTTESVILLE, Va., Jan. 31, 2023 /PRNewswire/ -- AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that…Super UserJanuary 31, 2023
News Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on…Super UserJanuary 31, 2023
News WBJ: Germantown’s Precigen raises $75M to advance treatments for rare diseases Germantown’s Precigen Inc. (NASDAQ: PGEN) has raised $75 million in a public offering that closed…Super UserJanuary 30, 2023